Back
Crinetics Pharmaceuticals Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
CRNX
Crinetics Pharmaceuticals
Last Price:
$53.86
Seasonality Move:
-9.59%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Crinetics Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Crinetics Pharmaceuticals has on average historically risen by 23% based on the past 6 years of stock performance.
-
Crinetics Pharmaceuticals has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Crinetics Pharmaceuticals Stock Undervalued?The current Crinetics Pharmaceuticals [CRNX] share price is $53.94. The Score for CRNX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Crinetics Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Crinetics Pharmaceuticals has on average historically risen by 23% based on the past 6 years of stock performance.
Crinetics Pharmaceuticals Stock Rating
Sell
30
Crinetics Pharmaceuticals (CRNX)
is a Sell
Is Crinetics Pharmaceuticals overpriced?
-
Crinetics Pharmaceuticals has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Crinetics Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
crinetics.com
52-Week Data
52-Week High:
62.53
52-Week Low:
33.67
Prediction Charts
Market Cap:
5B
Price in USD:
53.94
Volume:
150.3K
Beta:
0.67
Technical Analysis
SMA50:
56.86
SMA100:
54.35
SMA200:
50.60
52-Wk Change:
50.21%
Stock Predictions
-
Is Crinetics Pharmaceuticals stock public?Yes, Crinetics Pharmaceuticals is a publicly traded company.
-
What is the Crinetics Pharmaceuticals stock quote today?The Crinetics Pharmaceuticals stock price is 53.94 USD today.
-
How to buy Crinetics Pharmaceuticals stock online?You can buy Crinetics Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-5 | 56.92 | 57.69 | 58.27 | 56.04 |
| Dec-6 | 57.84 | 58.87 | 59.58 | 57.75 |
| Dec-9 | 58.74 | 56.62 | 59.63 | 56.57 |
| Dec-10 | 57.06 | 57.17 | 58.28 | 55.96 |
| Dec-11 | 57.54 | 60.15 | 60.34 | 57.02 |
| Dec-12 | 60.15 | 55.62 | 60.25 | 55.55 |
| Dec-13 | 55.53 | 53.66 | 56.53 | 53.36 |
| Dec-16 | 53.21 | 54.63 | 54.91 | 52.85 |
| Dec-17 | 54.23 | 55.37 | 56.15 | 53.04 |
| Dec-18 | 55.45 | 52.09 | 55.47 | 51.35 |
| Dec-19 | 52.08 | 52.74 | 53.05 | 50.82 |
| Dec-20 | 52.28 | 53.50 | 54.25 | 51.73 |
| Dec-23 | 53.22 | 53.96 | 54.09 | 52.47 |
| Dec-24 | 53.93 | 53.94 | 54.78 | 53.15 |
Crinetics Pharmaceuticals Earnings
Crinetics Pharmaceuticals Earnings Report: Per Share Crinetics Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Crinetics Pharmaceuticals Forecast Revenue Growth
Crinetics Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Crinetics Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and a decrease next year of $0.18 per share.
* Crinetics Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.